Fibroblast–tumor cell signaling limits HER2 kinase therapy response via activation of MTOR and antiapoptotic pathways

  • Ioannis K. Zervantonakis
  • , Matthew D. Poskus
  • , Alexis L. Scott
  • , Laura M. Selfors
  • , Jia Ren Lin
  • , Deborah A. Dillon
  • , Shailja Pathania
  • , Peter K. Sorger
  • , Gordon B. Mills
  • , Joan S. Brugge

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)16500-16508
Number of pages9
JournalProceedings of the National Academy of Sciences of the United States of America
Volume117
Issue number28
DOIs
StatePublished - Jul 14 2020

ASJC Scopus Subject Areas

  • General

Keywords

  • Breast cancer
  • Cell–cell interactions
  • Drug resistance
  • Fibroblasts
  • Tumor microenvironment

Fingerprint

Dive into the research topics of 'Fibroblast–tumor cell signaling limits HER2 kinase therapy response via activation of MTOR and antiapoptotic pathways'. Together they form a unique fingerprint.

Cite this